Alterome Therapeutics
About:
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Website: https://www.alterome.com
Top Investors: Blue Owl, Goldman Sachs, OrbiMed, Invus, Canaan Partners
Description:
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.
Total Funding Amount:
$231M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2021-01-01
Founders:
Eric A Murphy
Number of Employees:
11-50
Last Funding Date:
2024-04-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai